"Schmallenberg virus" - A novel orthobunyavirus emerging in Europe

Epidemiology and Infection

Volumn 141, Issue 1, 2013, Pages 1-8

  Beer, M ^a   Conraths, F J ^a   Van Der Poel, W H M ^b  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Schmallenberg virus

Indexed keywords

BOVIDS; CERATOPOGONIDAE; CONGENITAL MALFORMATION; CULICOIDES; DISEASE CARRIER; EPIDEMIC; EUROPE; INFECTION CONTROL; LIVESTOCK; MANDATORY REPORTING; NONHUMAN; ORTHOBUNYAVIRUS; ORTHOBUNYAVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCHMALLENBERG VIRUS; SCHMALLENBERG VIRUS INFECTION; SEROPREVALENCE; VERTICAL TRANSMISSION; VIREMIA; VIRUS DETECTION; VIRUS TRANSMISSION; ZOONOSIS;

ANIMAL DISEASES; ANIMALS; BUNYAVIRIDAE INFECTIONS; CERATOPOGONIDAE; COMMUNICABLE DISEASES, EMERGING; DISEASE VECTORS; EUROPE; ORTHOBUNYAVIRUS; RUMINANTS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84870867997     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812002245     Document Type: Review

References (22)

1. Hoffmann B, et al. Novel orthobunyavirus in cattle, Europe, 2011. Emerging Infectious Diseases 2012; 18: 469-472.
2. Yanase T, et al. Genetic reassortment between Sathuperi and Shamonda viruses of the genus Orthobunyavirus in nature: Implications for their genetic relationship to Schmallenberg virus. Archives of Virology 2012; 157: 1611-1618.
3. Goller KV, et al. Schmallenberg virus as possible ancestor of Shamonda virus. Emerging Infectious Diseases 2012; 18(10). doi 10.3201/eid1810.120835.
4. Parsonson IM, McPhee DA. Bunyavirus pathogenesis. Advances in Virus Research 1985; 40: 279-316.
5. van den Brom R, et al. Epizootic of ovine congenital malformations associated with Schmallenberg virus infection. Tijdschrift voor Diergeneeskunde 2012; 137: 106-111.
6. Gariglinany MM, et al. Schmallenberg virus in calf born at term with porencephaly, Belgium. Emerging Infectious Diseases 2012; 18: 1005-1006.
7. Elbers ARW, et al. Seroprevalence of Schmallenberg virus antibodies among dairy cattle, The Netherlands, Winter 2011-2012. Emerging Infectious Diseases 2012; 18: 1065-1071.
8. Anon. Evidence of seroconversion to SBV in camelids. Veterinary Record 2012; 170: 603.
9. ProMED mail. PRO/AH>Schmallenberg virus -Europe (26): vector, morphology. Archive number: 20120311.1066949.
10. Rasmussen LD, et al. Culicoids as vectors of Schmallenberg virus. Emerging Infectious Diseases 2012; 18: 1204-1206.
11. European Food Safety Authority. 'Schmallenberg' virus: Analysis of the epidemiological data and Impact assessment. EFSA Journal 2012; 10: 2768.
12. OIE. OIE Technical factsheet. May 2012. 1. Schmallenberg virus (http://www.oie.int/fileadmin/Home/fr/Our-scientific-expertise/docs/pdf/ A-Schmallenberg-virus.pdf). Accessed 20 September 2012.
13. European Centre for Disease Prevention and Control. 2012. New orthobunyavirus isolated from infected cattle and small livestock - potential implications for human health. (http://ecdc.europa.eu/en/publications/ Publications/TER-Joint-ECDC-RIVM-RKI-Rapid-Risk-Assessment-Schmallenberg-virus- May-2012.pdf). Accessed 20 September 2012.
14. Ducomble T, et al. Lack of evidence for Schmallenberg virus infection in highly exposed persons, Germany, 2012. Emerging Infectious Diseases 2012; 18: 1333-1335.
15. Reusken C, et al. Lack of evidence for zoonotic transmission of Schmallenberg virus. Emerging Infectious Diseases 2012, 18 (http://dx.doi.org/ 10.3201/eid1811. 120650). Accessed 20 September 2012.
16. Bilk S, et al. Organ distribution of Schmallenberg virus RNA in malformed newborns. Veterinary Microbiology 2012; 159: 236-8.
17. Anon. Serological ELISA for SBV currently being evaluated. Veterinary Record 2012; 170: 453.
18. Kurogi H, et al. Development of inactivated vaccine for Akabane disease. National Institute Animal Health Q (Tokyo) 1978; 18: 97-108. (Pubitemid 9087212)
19. Kim YH, et al. Development of inactivated trivalent vaccine for the teratogenic Aino, Akabane and Chuzan viruses. Biologicals 2011; 39: 152-157.
20. Eschbaumer M, et al. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Vaccine 2009; 27: 4169-4175.
21. Bird BH, et al. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. Journal of Virology 2011; 85: 12901-12909.
22. Jones KE, et al. Global trends in emerging infectious diseases. Nature 2008; 21: 990-993. (Pubitemid 351301726).